Table 1.
Patients’ clinical information.
| ndSR | dSR | AF | |
|---|---|---|---|
| Number of patients | 28 | 24 | 27 |
| Weight (mean±SD) (Kg) | 83.18 ± 9.86 | 71.5 ± 10.5 | 75.5 ± 11.386 |
| Height (mean±SD) (cm) | 169.4 ± 9.8 | 160.8 ± 8.7 | 163.8 ± 8.9 |
| Age (mean±SD) | 63.1 ± 9.7 | 73.5 ± 8.4 | 72.9 ± 9.4 |
| Sex (male/female) | 23/5 | 17/7 | 14/13 |
| Body Surface (mean ± SD) (m2) | 1.93 ± 0.14 | 1.75 ± 0.15 | 1.81 ± 0.15 |
| LA diameter index (mean ± SD) | 1.99 ± 0.17 | 2.6 ± 0.2 | 2.65 ± 0.55 |
| LV diameter index (mean ± SD) | 2.7 ± 0.5 | 2.83 ± 0.54 | 2.82 ± 0.42 |
| Tabaquism (y/n/ex) | 9/12/7 | 3/18/3 | 6/18/3 |
| Enolism (y/n/ex) | 0/28/0 | 1/23/0 | 1/26/0 |
| Hipertension | 25 | 22 | 20 |
| Diabetes | 11 | 12 | 9 |
| Dislipemia | 15 | 18 | 15 |
| Drugs | |||
| IECAs | 16 | 12 | 12 |
| Beta-bloquers | 12 | 9 | 16 |
| β1 | 3 | 2 | 8 |
| β2 | 0 | 0 | 1 |
| α | 0 | 0 | 0 |
| RyR-inhibitors | 0 | 0 | 0 |
| ARA-II | 5 | 4 | 2 |
| Ca2+ antagonist | 6 | 3 | 4 |
| Sintrom | 3 | 1 | 16 |
| AAS | 17 | 15 | 6 |
| Statins | 17 | 18 | 15 |